# Visiopharm · Pathology tissue image analysis software: AI\-based image analysis software for research and diagnostic \(EU\)

> We provide you with the accuracy and versatility you need to meet the tissue analysis challenges of tomorrow in research and diagnostics\. Whether you’re developing next\-generation therapies or matching these therapies with the right patients, we ensure the quality you need to stay ahead\.

Generated by Yoast SEO v28.3, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [About Visiopharm](https://visiopharm.com/about-us/)
- [Privacy policy](https://visiopharm.com/privacypolicy/)
- [Support](https://visiopharm.com/support/)
- [Diagnostic tissue analysis](https://visiopharm.com/diagnostics-pathology-image-analysis-software/)
- [Qualitopix](https://visiopharm.com/qualitopix/)

## Posts
- [From Manual Counting to AI\-Supported Assessments: How Växjö Pathology Lab Integrated AI into Clinical Practice](https://visiopharm.com/blog/customer-stories/from-manual-counting-to-ai-supported-ki-67-assessment-vaxjo-pathology-lab/)
- [How Kalmar County Hospital integrates AI biomarker assessment into clinical practice in Sweden  ](https://visiopharm.com/blog/customer-stories/kalmar-hospital-adds-diagnostic-biomarker-assessment-apps/)
- [How HistologiX answers complex biomarker questions in drug development ](https://visiopharm.com/blog/customer-stories/how-histologix-answers-complex-biomarker-questions-in-drug-development/)
- [Visiopharm software updates: 2026\.02\.1](https://visiopharm.com/product-releases/visiopharm-software-updates-2026-02-1/)
- [Visiopharm software updates: 2026\.08\.1](https://visiopharm.com/product-releases/software-whatsnew/)

## APP Posts
- [PD\-L1 APP, NSCLC ](https://visiopharm.com/app-center/app/ivdr-pdl1-app-nsclc/)
- [H\&E, Tumor Detection](https://visiopharm.com/app-center/app/he-tumor-detection/)
- [Tissue Detection, Fluorescence, 8bit](https://visiopharm.com/app-center/app/tissue-detection-if-8/)
- [Nuclei DAB Quantification](https://visiopharm.com/app-center/app/nuclei-dab-quantification/)
- [Nuclei DAB Intensity Quantification](https://visiopharm.com/app-center/app/nuclei-dab-intensity-quantification/)

## Resources
- [Visiopharm Tech Talks Session 2](https://visiopharm.com/resources/visiopharm-tech-talks-session-2/)
- [Insight brochure – EU/UK only](https://visiopharm.com/resources/insight-one-pager-eu-uk-only/)
- [From multiplex images to spatial insights: Defining the tumor–stroma landscape of desmoplastic small round cell tumor](https://visiopharm.com/resources/from-multiplex-images-to-spatial-insights-defining-the-tumor-stroma-landscape-of-desmoplastic-small-round-cell-tumor/)
- [Anti\-CSF\-1R therapy in combination with immunochemotherapy coordinates an adaptive immune response that eliminates macrophage\-enriched triple\-negative breast cancers](https://visiopharm.com/resources/anti-csf-1r-therapy-in-combination-with-immunochemotherapy-coordinates-an-adaptive-immune-response-that-eliminates-macrophage-enriched-triple-negative-breast-cancers/)
- [Visiopharm Tech Talks Session 1](https://visiopharm.com/resources/visiopharm-tech-talks-session-1/)

## Optional
- [Sitemap index](https://visiopharm.com/sitemap_index.xml)